Patrizia Carpinelli Selected Research

3-aminopyrazole

12/2007

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrizia Carpinelli Research Topics

Disease

10	Neoplasms (Cancer) 12/2021 - 07/2006
2	Neuroblastoma 12/2021 - 07/2016
2	Hematologic Neoplasms (Hematological Malignancy) 07/2015 - 09/2007
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2015 - 09/2007
1	2-Hydroxyglutaricaciduria 10/2016
1	Philadelphia Chromosome 07/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2015
1	Brain Neoplasms (Brain Tumor) 09/2013
1	Carcinogenesis 04/2010
1	Neutropenia 10/2009

Drug/Important Bio-Agent (IBA)

7	Aurora KinasesIBA 12/2021 - 09/2007
5	danusertibIBA 07/2015 - 09/2007
3	Phosphotransferases (Kinase)IBA 09/2013 - 09/2007
2	Biological ProductsIBA 10/2016 - 02/2012
2	Imatinib Mesylate (Gleevec)FDA Link 07/2015 - 09/2007
2	Pharmaceutical PreparationsIBA 02/2012 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 02/2012 - 01/2008
1	Aurora Kinase AIBA 12/2021
1	PHA 680626IBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	Polo-Like Kinase 1IBA 01/2018
1	alpha-hydroxyglutarateIBA 10/2016
1	LigandsIBA 07/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2016
1	Cisplatin (Platino)FDA LinkGeneric 07/2016
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	EnzymesIBA 04/2010
1	tyrosine receptor (receptor, tyrosine)IBA 12/2007
1	3-aminopyrazoleIBA 12/2007
1	PHA 680632IBA 07/2006

Therapy/Procedure

5	Therapeutics 07/2015 - 09/2007